{"filing":{"accession_number":"0001493152-26-038039","cik":"0001213809","ticker":"DYAI","company_name":"DYADIC INTERNATIONAL INC","form":"8-K","filing_date":"2026-08-14","report_date":"2026-08-13","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1213809/000149315226038039/form8-k.htm"},"events":[{"id":27793,"run_id":25367,"accession_number":"0001493152-26-038039","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.94,"summary":"Dyadic International completed a registered direct offering of 3,625,000 shares at $0.795 per share combined with a concurrent private placement of 3,625,000 warrants to purchase additional shares, generating approximately $2.9 million in gross proceeds. This dilutive capital raise combines registered and unregistered equity securities and materially dilutes existing shareholders.","company_name":"DYADIC INTERNATIONAL INC","ticker":"DYAI","filing_date":"2026-08-14","form":"8-K","submitted_at":null,"items":[{"id":29469,"accession_number":"0001493152-26-038039","item_number":"1.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Dyadic entered into a registered direct offering of 3,625,000 shares at $0.795 per share and a concurrent private placement of warrants to purchase an additional 3,625,000 shares at $0.84 per share, generating approximately $2.9 million in gross proceeds. This is a dilutive equity issuance combining registered and unregistered securities, typical of small-cap biotechnology companies raising capital. The warrant component and the pricing ($0.795 per share) suggest financial stress and dilution to existing shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T13:18:52.260645+00:00","company_name":"","ticker":null,"filing_date":""},{"id":29470,"accession_number":"0001493152-26-038039","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 3.02 discloses an unregistered private placement of Common Warrants to purchase 3,625,000 shares of Common Stock, offered to accredited investors pursuant to Section 4(a)(2) and Rule 506. The concurrent registered direct offering of 3,625,000 shares of Common Stock, combined with the warrant issuance, represents a dilutive capital raise of approximately $2.9 million. This is a classic dilutive issuance structure combining registered and unregistered equity securities to raise capital.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T13:18:52.260645+00:00","company_name":"","ticker":null,"filing_date":""},{"id":29471,"accession_number":"0001493152-26-038039","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Dyadic International announced a registered direct offering of 3,625,000 shares of common stock at $0.795 per share, combined with a concurrent private placement of 3,625,000 warrants at $0.005 per warrant, generating approximately $2.9 million in gross proceeds. This is a classic dilutive equity issuance combining a registered offering and a private placement of warrants, which would materially dilute existing shareholders and is a significant capital-raising event for the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T13:18:52.260645+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":29469,"accession_number":"0001493152-26-038039","item_number":"1.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Dyadic entered into a registered direct offering of 3,625,000 shares at $0.795 per share and a concurrent private placement of warrants to purchase an additional 3,625,000 shares at $0.84 per share, generating approximately $2.9 million in gross proceeds. This is a dilutive equity issuance combining registered and unregistered securities, typical of small-cap biotechnology companies raising capital. The warrant component and the pricing ($0.795 per share) suggest financial stress and dilution to existing shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T13:18:52.260645+00:00","company_name":"DYADIC INTERNATIONAL INC","ticker":"DYAI","filing_date":"2026-08-14"},{"id":29470,"accession_number":"0001493152-26-038039","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 3.02 discloses an unregistered private placement of Common Warrants to purchase 3,625,000 shares of Common Stock, offered to accredited investors pursuant to Section 4(a)(2) and Rule 506. The concurrent registered direct offering of 3,625,000 shares of Common Stock, combined with the warrant issuance, represents a dilutive capital raise of approximately $2.9 million. This is a classic dilutive issuance structure combining registered and unregistered equity securities to raise capital.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T13:18:52.260645+00:00","company_name":"DYADIC INTERNATIONAL INC","ticker":"DYAI","filing_date":"2026-08-14"},{"id":29471,"accession_number":"0001493152-26-038039","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Dyadic International announced a registered direct offering of 3,625,000 shares of common stock at $0.795 per share, combined with a concurrent private placement of 3,625,000 warrants at $0.005 per warrant, generating approximately $2.9 million in gross proceeds. This is a classic dilutive equity issuance combining a registered offering and a private placement of warrants, which would materially dilute existing shareholders and is a significant capital-raising event for the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T13:18:52.260645+00:00","company_name":"DYADIC INTERNATIONAL INC","ticker":"DYAI","filing_date":"2026-08-14"}]}